health pharma news today obesity drugs glp-1 Drugmaker Eli Lilly announced that the FDA approved its daily pill, which will be marketed under the name Foundayo, to treat obesity. ABC News' Youri Benadjaoud reports health pharma news today obesity
Description
Nearly a quarter stopped drinking alcohol entirely and nearly 20% gave up sugary drinks
[DOI] [PubMed] [Google Scholar] 67.Lovshin JA, Barnie A, DeAlmeida A, Logan A, Zinman B, Drucker DJ
Most of the strongest evidence linking GLP-1 drugs to potential MS benefits comes from animal and laboratory studies
This review explores factors that may contribute to accelerated muscle loss among higher-risk patient populations and describes tailored interventions to reduce the risk of accelerated sarcopenia and frailty
& Viollet, B
